IVDR is a marathon, not a sprint. We’ll help you go the distance.

Explore our IVDR-reagent portfolio

Accelerate Your Antibody Discovery & Development with ValitaTiter Assays

Request a demo

We are Making Flow Cytometry more Accessible

Discover the Flow Cytometry Learning Center

Straight up, it's better!
Discover a faster path home.

Learn more

Automated Bioreactor Sample Delivery to the Vi-CELL BLU Cell Viability Analyzer

See how it works

A Diferença Beckman Coulter Ciências da Vida

O comprometimento da Beckman Coulter com sua pesquisa é datado desde nossa origem em 1935. Por mais de 80 anos, nós somos parceiros confiáveis para profissionais de laboratório, ajudando a avançar a pesquisa científica e cuidado ao paciente. A Beckman Coulter Ciências da Vida e Beckman.com é um recurso global para milhões de pesquisadores de ciência da vida, técnicos industriais e ambientais, e cientistas farmacêuticos e biomédicos.

Saiba mais

Últimas notícias e atualizações

Nota de Imprensa

Beckman Coulter Life Sciences Achieves Industry-First Reagent Certification to Help Prepare Labs for IVDR and to Clear Confusion

INDIANAPOLIS – (April 17, 2023) – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, is leading the way to help laboratories prepare for critical upgrades to comply with the new In Vitro Diagnostic Medical Devices Regulation (IVDR), and to clear up confusion for laboratories that will soon be governed by IVDR.

Leia mais
Nota de Imprensa

Beckman Coulter Life Sciences Completes First Phase of Colorado Research and Development Hub with Grand Opening of $10 Million Loveland Offices

LOVELAND, CO – (January 19, 2023) – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, further strengthens its commitment to the greater Loveland, Colorado community with the completion of the first phase of its new research and development hub.

Leia mais
Nota de Imprensa

Beckman Coulter Life Sciences and Pillar Biosciences Sign Application Development Agreement for the Biomek NGeniuS System

INDIANAPOLIS – (October 31, 2022) – More companies around the world continue turning to Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, for their next generation sequencing (NGS) needs with the Biomek NGeniuS System. The company continues building a robust demonstrated application library as it announces an application development agreement with Pillar Biosciences, which specializes in developing and commercializing IVD & RUO NGS testing solutions that help research to optimize selection of precision therapies for cancer patients, from tumor profiling to therapy selection, and recurrence monitoring.  

Leia mais